Biogen
BIIB
#1060
Rank
ยฃ12.95 B
Marketcap
ยฃ88.50
Share price
2.88%
Change (1 day)
-43.60%
Change (1 year)

Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.

Biogen (BIIB) - Net assets

Net assets on the balance sheet as of December 2024 : ยฃ12.47 Billion

According to Biogen's latest financial reports the company has ยฃ12.47 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Biogen - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2024-12-31$ยฃ13.32 B14.67%
2023-12-31$ยฃ11.61 B4.97%
2022-12-31$ยฃ11.06 B36.3%
2021-12-31$ยฃ8.11 B3.57%
2020-12-31$ยฃ7.83 B-22.93%
2019-12-31$ยฃ10.17 B-0.91%
2018-12-31$ยฃ10.26 B10.14%
2017-12-31$ยฃ9.32 B-5.17%
2016-12-31$ยฃ9.82 B55.38%
2015-12-31$ยฃ6.32 B-8.92%
2014-12-31$ยฃ6.94 B32.9%
2013-12-31$ยฃ5.22 B21.3%
2012-12-31$ยฃ4.30 B4.2%
2011-12-31$ยฃ4.13 B17.14%
2010-12-31$ยฃ3.53 B-8.77%
2009-12-31$ยฃ3.86 B-2.79%
2008-12-31$ยฃ3.98 B42.89%
2007-12-31$ยฃ2.78 B-23.68%
2006-12-31$ยฃ3.65 B-8.85%
2005-12-31$ยฃ4.00 B12.62%
2004-12-31$ยฃ3.55 B-9.82%
2003-12-31$ยฃ3.94 B469.73%
2002-12-31$ยฃ0.69 B-25.61%
2001-12-31$ยฃ0.93 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
ยฃ4.38 B-64.84%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ14.36 B 15.14%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ2.51 B-79.88%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ66.03 B 429.41%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ53.34 B 327.67%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ0.14 Billion-101.11%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ60.45 B 384.68%๐Ÿ‡ซ๐Ÿ‡ท France
ยฃ4.90 B-60.70%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.77 B-85.80%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ2.66 B-78.66%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands